
No, AI agents did not discover a previously unknown Maya site
The Maya site story isn't an argument against AI in science. It's a reminder that spotting something isn't the same as discovering it, and experts usually end up doing the cleanup.
Desk
Google, DeepMind, and Gemini developments.

The Maya site story isn't an argument against AI in science. It's a reminder that spotting something isn't the same as discovering it, and experts usually end up doing the cleanup.

Parents aren't rejecting AI in the abstract; they're rejecting a school default they can't switch off, can't audit, and can't get a straight answer about.

DeepMind workers are using UK labor law to force a vote, and what they want to bargain over is not pay but which militaries their AI serves.

Google's cheaper, faster Gemini 4 tier is the version most people will actually touch, and its safety claims matter more than its benchmarks because of that reach.

Google just put its newest model in front of every Search user at once, and the real test is whether smarter answers still send people out to the open web.

Chatbots are becoming shopping assistants, and a new test shows they sometimes point people to knockoff and impostor stores right before the holiday rush.

Google's first Gemini glasses lead with privacy guardrails that go further than Meta's, but the real test is whether an assistant without a screen can be trusted to get things right.

Apple's first smart display arrives years after Amazon and Google defined the category, and its pitch rests on whether a newly capable Siri can make a kitchen screen genuinely useful.
AlphaGenome 2 moves DNA modeling from tissue averages to individual cell types, which is where many disease variants actually do their damage, but access stays hosted and non-commercial for now.

Google built a model that doesn't write answers at all, it just picks them, and that small design choice could make AI agents cheaper, faster and easier to audit.

Google's Tabletop turns group chats into small custom apps built by prompt, a genuinely handy idea for families and friends that also raises fresh questions about who it's for.

AlphaGenome 2 moves DNA prediction from the whole genome down to individual cell types. That's where drug targets actually live, and it's AI for science at its most useful.